Letters
Opening up data at the EMA
Still waiting for functional EU Clinical Trials Register
BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d3834 (Published 20 June 2011) Cite this as: BMJ 2011;342:d3834
- Beate Wieseler, deputy head, Department of Drug Assessment1,
- Natalie McGauran, researcher1,
- Thomas Kaiser, head, Department of Drug Assessment1
- 1Institute for Quality and Efficiency in Health Care, 51105 Cologne, Germany
- beate.wieseler{at}iqwig.de
Gøtzsche and Jørgensen’s comprehensive account of their efforts to obtain clinical trial data from the European Medicines Agency (EMA) highlights the problems researchers still face in healthcare evaluation.1 In its response, the EMA refers to the steps it has undertaken to improve transparency, including the long awaited launch of the EU Clinical Trials Register (EU-CTR).2
The major goal of trial …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.